TargImmune Therapeutics

Basel, Switzerland

TargImmune Therapeutics is focused on drug development using novel targeted onco-immunotherapies.

Jul 2021

Venture - Series Unknown

Biotechnology Health Care Pharmaceutical

Top Investors

EISMEA

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about TargImmune Therapeutics

Who are TargImmune Therapeutics's investors?

TargImmune Therapeutics's investors include EISMEA.

Where is TargImmune Therapeutics headquartered?

TargImmune Therapeutics is headquartered in Basel, Switzerland.

What does TargImmune Therapeutics do?

TargImmune Therapeutics is focused on drug development using novel targeted onco-immunotherapies.

What stage is TargImmune Therapeutics at?

TargImmune Therapeutics is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated July 19, 2021.

MLA

"TargImmune Therapeutics — Funding & Investors." VCBacked, July 19, 2021, https://www.vcbacked.co/company/targimmune-therapeutics. Accessed July 1, 2026.

APA

VCBacked. (2021). TargImmune Therapeutics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/targimmune-therapeutics

Wikipedia (cite web)

{{cite web |title=TargImmune Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/targimmune-therapeutics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated July 19, 2021.